Table 4.
Study ID | Random Sequence Generation |
Allocation Concealment | Blinding of Participants and Personnel |
Blinding of Outcome Assessors |
Incomplete Outcome Data | Selective Reporting | Other Bias | Overall Quality |
---|---|---|---|---|---|---|---|---|
Baum 2015 | Unclear risk | High risk | High risk | High risk | Low risk | Low risk | Low risk | High risk |
Bellissimo2020 | Low risk | Low risk | Low risk | Unclear risk | Low risk | Low risk | Low risk | Unclear risk |
Douglas2019 | Unclear risk | High risk | High risk | High risk | Low risk | Low risk | Low risk | High risk |
Kral2016 | Unclear risk | High risk | Unclear risk | High risk | Low risk | Low risk | Low risk | High risk |
Leidy2010 | Unclear risk | High risk | High risk | High risk | Unclear risk | Low risk | Low risk | High risk |
Leidy2013 | Unclear risk | High risk | High risk | High risk | Low risk | Low risk | Low risk | High risk |
Liu2015 | Low risk | Low risk | Unclear risk | High risk | Low risk | Low risk | Low risk | High risk |
Mehrabani2015 | Low risk | Low risk | Low risk | High risk | Unclear risk | Low risk | Low risk | High risk |
Wang2014 | Low risk | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Low risk | High risk |
Wang2015 | Low risk | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Low risk | High risk |